Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
ERJ Open Research|October 22, 2025
Longer term post-hospital morbidity and mortality following admission with COVID-19: a systematic review and meta-analysisJoseph Newman, Luke Flower, Rowena Jones, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2013
Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomesAdam B Shapiro, Joseph Newman, Kosalaram Goteti, et al.
Life (Basel, Switzerland)|April 30, 2021
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a ScaffoldJessica Swanson, Rennos Fragkoudis, Philippa C Hawes, et al.
Journal of Virology|October 20, 2017
Deep Sequencing of Foot-and-Mouth Disease Virus Reveals RNA Sequences Involved in Genome PackagingGrace Logan, Joseph Newman, Caroline F Wright, et al.
The Journal of General Virology|April 4, 2022
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host rangesNazia Thakur, Giulia Gallo, Joseph Newman, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017Ian Morrissey, Stephen Hawser, Sibylle H Lob, et al.
Journal of Bacteriology|August 2, 2011
RNase Y in Bacillus subtilis: a Natively disordered protein that is the functional equivalent of RNase E from Escherichia coliMartin Lehnik-Habrink, Joseph Newman, Fabian M Rothe, et al.
Plos Pathogens|July 16, 2026
Induction of neutralising antibodies against conserved rhinovirus capsid protein VP4 is dependent on presentation of VP4 peptide immunogens in a virus-like conformationJames T Kelly, Giann Kerwin Y Dellosa, Joseph Newman, et al.
Viruses|March 28, 2026
Characterisation of Naturally Occurring MERS-CoV Spike Mutations and Their Impact on Fusion and NeutralisationRachael Dempsey, Hannah Goldswain, Joseph Newman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgeneMargret S Fernandes, Erica M Gomes, Lindsay D Butcher, et al.
Pageof 7